Working to Eradicate Gynecologic Cancers

Mario Mendes Leitao, MD

Associate Member
Memorial Sloan Kettering Cancer Center
Dept. of Surgery
1275 York Ave.
New York, NY
USA 10065


Biographical Sketch:
I have been performing gynecologic surgeries with the robotic platform since 2006. Currently, I serve as Co-Director of the Robotic Surgery Program for the Department of Surgery at Memorial Sloan-Kettering Cancer Center. We have been using the robotic platform increasingly for more advanced gynecologic oncology procedures including splenectomy, bowel resections, and tumor cytoreduction. We have published our experience incorporating the platform and continue to analyze our experience."

Papers:
10 Multicenter study comparing two approaches to nodal assessment in patients with low-risk endometrial carcinoma: contemporary sentinel lymph node mapping versus historical selective systematic surgical staging 11 Multicenter study assessing the detection of stage IIIC endometrial cancer in intermediate- and high-risk tumors between a contemporary sentinel node mapping vs. historical comprehensive lymphadenectomy approach 16 Sentinel lymph node mapping using robotic-assisted fluorescence imaging 18 Sentinel inguinofemoral lymph node identification in vulvar cancer and the use of near-infrared imaging for sentinel lymph node detection 22 The impact of intraoperative tumor fragmentation or morcellation in patients with early-stage uterine leiomyosarcoma 24 Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: an NRG Oncology/Gynecologic Oncology Group study 50 Outcomes in low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma 75 An international comparison of surgically staged patients with serous and clear cell endometrial carcinoma 76 An international comparison of surgical staging approaches in patients with intermediate- and high-risk endometrioid endometrial cancer 77 Outcomes of patients with stage I endometrial cancer in the sentinel lymph node era 80 Do stage I-II uterine clear cell carcinoma patients need to be treated as aggressively as patients with serous carcinoma? 87 An international collaboration for comparison of two approaches to surgical staging of low-risk endometrial cancer 88 Impact of obesity on sentinel lymph node mapping in patients with newly diagnosed uterine cancer undergoing robotic surgery 91 A multicenter prospective assessment of surgical findings associated with suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube and peritoneal cancer 104 Improvement in rates of cytoreduction to no residual for stages IIIB-IV ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach and individualized surgeon feedback 109 Cost-effectiveness analysis of conventional laparoscopic versus robotically assisted laparoscopic adnexal surgery for benign indications performed by gynecologic oncologists 127 International study of primary mucinous ovarian carcinomas managed at tertiary medical centers 183 Radical hysterectomy: programmatic change to reduce laparotomy rate while maintaining oncologic outcome for early stage cervical cancer 244 Sentinel lymph node mapping in patients with vulvar malignancies using indocyanine green and near-infrared imaging: preliminary detection rate experience 292 Combined preoperative and extended pharmacologic venous thromboembolic prophylaxis in patient undergoing surgery for advanced adnexal malignancies 315 Cost-effectiveness analysis of robotically assisted radical hysterectomy for newly diagnosed uterine cervical cancer 355 Impact of smoking on survival among women treated with and without bevacizumab for advanced cervical cancer (CxCA): an NRG Oncology/Gynecologic Oncology Group study 434 Multi-institutional validation of decreased survival with venous thromboembolism in ovarian clear cell carcinoma 446 Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing surgery for advanced ovarian cancer 495 Survival in patients with uterine carcinosarcoma undergoing sentinel lymph node mapping